Michael J. Valentino, President & CEO at Adams Respiratory Therapeutics, Inc. (ARXT), sold 33,400 shares at $39.62 ($1.3M) on 2007-07-02, disclosed to the SEC on 2007-07-05.
Scheduled sale ($1.3M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.27 | 2,400 | $94K | 7.2% |
| 2 | $39.28 | 600 | $24K | 1.8% |
| 3 | $39.29 | 100 | $4K | 0.3% |
| 4 | $39.30 | 100 | $4K | 0.3% |
| 5 | $39.31 | 600 | $24K | 1.8% |
| 6 | $39.32 | 1,200 |
| $47K |
| 3.6% |
| 7 | $39.33 | 500 | $20K | 1.5% |
| 8 | $39.34 | 800 | $31K | 2.4% |
| 9 | $39.35 | 1,300 | $51K | 3.9% |
| 10 | $39.36 | 500 | $20K | 1.5% |
| 11 | $39.37 | 300 | $12K | 0.9% |
| 12 | $39.38 | 1,300 | $51K | 3.9% |
| 13 | $39.39 | 1,500 | $59K | 4.5% |
| 14 | $39.40 | 3,928 | $155K | 11.8% |
| 15 | $39.41 | 1,272 | $50K | 3.8% |
| 16 | $39.42 | 1,400 | $55K | 4.2% |
| 17 | $39.43 | 1,000 | $39K | 3.0% |
| 18 | $39.44 | 1,700 | $67K | 5.1% |
| 19 | $39.45 | 1,900 | $75K | 5.7% |
| 20 | $39.46 | 1,000 | $39K | 3.0% |
| 21 | $39.47 | 2,085 | $82K | 6.3% |
| 22 | $39.48 | 1,200 | $47K | 3.6% |
| 23 | $39.49 | 1,599 | $63K | 4.8% |
| 24 | $39.50 | 3,116 | $123K | 9.3% |
| 25 | $39.51 | 1,300 | $51K | 3.9% |
| 26 | $39.52 | 100 | $4K | 0.3% |
| 27 | $39.53 | 100 | $4K | 0.3% |
| 28 | $39.55 | 400 | $16K | 1.2% |
| 29 | $39.62 | 100 | $4K | 0.3% |
| Total | $39.41 avg | 33,400 | $1.3M | 100% |
| Filing → |
| PLXP | BUY | 2020-11-20 | $1.0M | — | Filing → |
| PLXP | BUY | 2019-05-21 | $497K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $400K | — | Filing → |